The company is a high-tech service enterprise with third-party medical testing and pathological diagnosis services as the core. Through continuous accumulation of core resource advantages such as “big platform, big network, big service, large sample and big data”, the company is committed to providing leading medical diagnosis information integration services for medical institutions at all levels across the country. The company is a high-tech service enterprise with third-party medical testing and pathological diagnosis business as the core. The company's main products include mass spectrometry, genomics, pathology, biochemiluminescence, immunology, and other synthesis. Corporate honors: It won the “2018 Responsible Brand Award” at the 8th China Charity Festival; the “2018 Social Responsibility · Health Public Welfare Poverty Alleviation Contribution Award” was awarded in the “2018 New Express - New Backbone · New Motivation” event; and the “China County Hospital's Most Influential Discipline Co-construction Award” was awarded at the 2019 China Health County Conference. The company was honored with the “Guangdong Guangcai Business Contribution Award”, “Guangzhou Five-Star Charity Unit”, the 4th “China Quality Award Nomination Award” and the 19th “National Quality Award Nomination Award”.
No Data
No Data